A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
Clinical trial NCT00810953 · COMPLETED
Trial details
- NCT number
- NCT00810953
- Sponsor
- Oncozyme Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.